Literature DB >> 15060447

Ritonavir boosted indinavir treatment as a simplified maintenance "mono"-therapy for HIV infection.

Christian Kahlert1, Maria Hupfer, Thomas Wagels, Daniel Bueche, Walter Fierz, Ulrich A Walker, Pietro L Vernazza.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2004        PMID： 15060447     DOI： 10.1097/00002030-200404090-00017

Source DB:  PubMed          Journal:  AIDS        ISSN： 0269-9370            Impact factor:   4.177


× No keyword cloud information.
  5 in total

1.  Potential risks and benefits of HIV treatment simplification: a simulation model of a proposed clinical trial.

Authors:  Bruce R Schackman; Callie A Scott; Paul E Sax; Elena Losina; Timothy J Wilkin; John E McKinnon; Susan Swindells; Milton C Weinstein; Kenneth A Freedberg
Journal:  Clin Infect Dis       Date:  2007-09-04       Impact factor: 9.079

Review 2.  Simplification strategies to reduce antiretroviral drug exposure: progress and prospects.

Authors:  John E McKinnon; John W Mellors; Susan Swindells
Journal:  Antivir Ther       Date:  2009

3.  Late treatment failures in cerebrospinal fluid in patients on long-term maintenance ART with ritonavir-boosted protease PI monotherapy.

Authors:  C Kahlert; A Bregenzer; C Gutmann; S Otterbech; M Hoffmann; P Schmid; P Vernazza
Journal:  Infection       Date:  2015-12-11       Impact factor: 3.553

4.  Regimen simplification to atazanavir-ritonavir alone as maintenance antiretroviral therapy: final 48-week clinical and virologic outcomes.

Authors:  Timothy J Wilkin; John E McKinnon; A Gregory DiRienzo; Katie Mollan; Courtney V Fletcher; David M Margolis; Barbara Bastow; Gary Thal; William Woodward; Catherine Godfrey; Ann Wiegand; Frank Maldarelli; Sarah Palmer; John M Coffin; John W Mellors; Susan Swindells
Journal:  J Infect Dis       Date:  2009-03-15       Impact factor: 5.226

5.  Baseline natural killer and T cell populations correlation with virologic outcome after regimen simplification to atazanavir/ritonavir alone (ACTG 5201).

Authors:  John E McKinnon; Robbie B Mailliard; Susan Swindells; Timothy J Wilkin; Luann Borowski; Jillian M Roper; Barbara Bastow; Mary Kearney; Ann Wiegand; John W Mellors; Charles R Rinaldo
Journal:  PLoS One       Date:  2014-05-06       Impact factor: 3.240
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.